February 18, 2025 · Form 4 insider transaction
Drugs Made In America Acquisition LLC bought 30,000 shares of DMAA, a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Reflects the 30,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $300,000.